Spinal Cord Stimulation Restores Neural Function in SMA Patients
A groundbreaking clinical trial has demonstrated that spinal cord stimulation can help restore motor function in patients with spinal muscle atrophy (SMA), a severe neurodegenerative disease. Researchers at the University of Pittsburgh found that this drug-free, minimally invasive therapy improves muscle strength, walking ability, and fatigue levels, offering a new hope for treating neurodegenerative conditions.
Spinal Cord Stimulation: A New Approach to SMA Treatment
SMA is a genetic disorder that causes progressive loss of motor neurons, leading to severe muscle weakness and movement impairments. Current treatments, including gene therapy and medications, focus on slowing disease progression but do not reverse damage to nerve cells.
In this new study, researchers used spinalcord electrical stimulation to reactivate silent motor neurons, essentially rewiring neural connections to improve mobility and muscle function.
“To counteract neurodegeneration, we need two things—stop neuron death and restore function of surviving neurons,” said Dr. Marco Capogrosso, study co-author.
Clinical Trial Results: A Life-Changing Breakthrough
Three SMA patients participated in a 29-day pilot trial, undergoing spinalcord stimulation five times a week. The results were remarkable:
✔ All participants showed improved motor function
✔ Increased walking endurance by at least 20 meters
✔ Reduced fatigue and improved daily activity performance
✔ Improved motoneuron electrical function and strength
“Patients don’t expect to get better over time—but that’s exactly what we saw,” said Dr. Elvira Pirondini.
This therapy offers a potential alternative for other neurodegenerative diseases, including ALS and Huntington’s disease, by stimulating damaged neural pathways to restore movement.
Future Prospects: Expanding the Treatment
With encouraging early results, researchers plan to launch larger clinical trials to determine the long-term effectiveness of this approach. If successful, spinal cord stimulation could redefine treatment strategies for neurodegenerative diseases, providing millions of patients with renewed mobility and hope.
More Information: First-in-human study of epidural spinal cord stimulation in individuals with spinal muscular atrophy, Nature Medicine (2025). DOI: 10.1038/s41591-024-03484-8.
more recommended stories
-
Canada Sees 17.6% Rise in Alcohol Deaths Amid Pandemic
COVID-19 Fueled Alcohol Deaths & Hospitalizations.
-
Surge in Non-Smokers Lung Cancer Tied to Pollution
Air Pollution Drives Lung Cancer Surge.
-
α-Synuclein Spreads From Kidneys to Brain
The Link Between Renal Failure and.
-
Autism Origins: Study Debunks Maternal Health Myths
A large-scale NYU Langone Health study.
-
AI and 3D Printing Unlock New Neuron Growth Insights
3D-Printing Brain Model Unlocks Neuron Growth.
-
AI Uncovers Hidden Pregnancy Risks for Stillbirth
A groundbreaking AI-driven study has identified.
-
Harvard Study Unveils New TB Drug Regimens
A Harvard Medical School-led clinical trial.
-
Chemotherapy Side Effect: Chronic Nerve Pain in 40%
A recent global study published in.
-
Largest Cannabis Brain Study Finds Memory Impairment
New Study Reveals Cannabis’ Impact on.
-
How Long to Form a Habit? Study Reveals Surprising Insights
A recent systematic review published in.
Leave a Comment